The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population

H Henry Lai, Baixin Shen, Amar Rawal, Joel Vetter, H Henry Lai, Baixin Shen, Amar Rawal, Joel Vetter

Abstract

Background: To investigate the relationship between depression and overactive bladder (OAB)/urinary incontinence symptoms among the clinical OAB population.

Methods: Patients who were diagnosed with overactive bladder (OAB) and age-matched control subjects without OAB were enrolled. Depression symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS-D). OAB/incontinence symptoms were assessed using the validated questionnaires: ICIQ-UI, ICIQ-OAB, UDI-6, IIQ-7, and OAB-q.

Results: 27.5 % of OAB patients in our study had depression (HADS ≥8), and 12 % of OAB patients had moderate to severe depression (HADS-D ≥11). OAB patients reported significantly higher HADS-D depression scores compared to age-matched controls (5.3 ± 3.9 versus 2.8 ± 3.9, p = 0.004). OAB patients with depression reported more severe incontinence symptoms (ICIQ-UI), greater bother and more impact on quality of life (UDI-6, IIQ-7) compared to OAB patients without depression (p = 0.001, 0.01, <0.001, respectively). However there were no differences in ICIQ-OAB and OAB-q. Among OAB patients, there were positive correlations between the severity of depression symptoms and OAB/incontinence symptoms (p-values <0.001 to 0.035).

Conclusions: 27.5 % of OAB patients have depression. OAB patients with depression reported more severe urinary incontinence symptoms, greater bother and more impact on quality of life compared to those without depression. Future studies are needed to further examine the mechanistic links between depression and OAB/urinary incontinence.

Keywords: Depression; Overactive bladder; Psychosocial; Urinary incontinence; Urinary urgency.

Figures

Fig. 1
Fig. 1
OAB patients with anxiety had higher incontinence scoresᅟ

References

    1. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327.
    1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167. doi: 10.1002/nau.10052.
    1. Vrijens D, Drossaerts J, van Koeveringe G, et al. Affective symptoms and the overactive bladder - a systematic review. J Psychosom Res. 2015;78:95. doi: 10.1016/j.jpsychores.2014.11.019.
    1. Melville JL, Walker E, Katon W, et al. Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. Am J Obstet Gynecol. 2002;187:80. doi: 10.1067/mob.2002.124839.
    1. Sung VW, West DS, Hernandez AL, et al. Association between urinary incontinence and depressive symptoms in overweight and obese women. Am J Obstet Gynecol. 2009;200:557 e1. doi: 10.1016/j.ajog.2008.11.008.
    1. Chiara G, Piccioni V, Perino M, et al. Psychological investigation in female patients suffering from urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9:73. doi: 10.1007/BF01982211.
    1. Stach-Lempinen B, Hakala AL, Laippala P, et al. Severe depression determines quality of life in urinary incontinent women. Neurourol Urodyn. 2003;22:563. doi: 10.1002/nau.10137.
    1. Zorn BH, Montgomery H, Pieper K, et al. Urinary incontinence and depression. J Urol. 1999;162:82. doi: 10.1097/00005392-199907000-00020.
    1. Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188:2455. doi: 10.1016/j.juro.2012.09.079.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res. 1997;42:17. doi: 10.1016/S0022-3999(96)00216-4.
    1. Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23:322. doi: 10.1002/nau.20041.
    1. Jackson S, Donovan J, Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77:805. doi: 10.1046/j.1464-410X.1996.00186.x.
    1. Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11:563. doi: 10.1023/A:1016370925601.
    1. Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14:131. doi: 10.1002/nau.1930140206.
    1. de Groat WC. Influence of central serotonergic mechanisms on lower urinary tract function. Urology. 2002;59:30. doi: 10.1016/S0090-4295(01)01636-3.
    1. Steers WD, Herschorn S, Kreder KJ, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 2007;100:337. doi: 10.1111/j.1464-410X.2007.06980.x.
    1. Perry S, McGrother CW, Turner K, et al. An investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological model. Br J Health Psychol. 2006;11:463. doi: 10.1348/135910705X60742.
    1. Nuotio M, Luukkaala T, Tammela TL, et al. Six-year follow-up and predictors of urgency-associated urinary incontinence and bowel symptoms among the oldest old: a population-based study. Arch Gerontol Geriatr. 2009;49:e85. doi: 10.1016/j.archger.2008.08.009.
    1. Hirayama A, Torimoto K, Mastusita C, et al. Risk factors for new-onset overactive bladder in older subjects: results of the Fujiwara-kyo study. Urology. 2012;80:71. doi: 10.1016/j.urology.2012.04.019.
    1. Esin E, Ergen A, Cankurtaran M, et al. Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder. Aging Ment Health. 2015;19:217. doi: 10.1080/13607863.2014.922528.
    1. Levin PJ, Siddiqui NY, Wu JM, et al. Psychosocial factors related to the use of InterStim(R) for the treatment of refractory overactive bladder. Female Pelvic Med Reconstr Surg. 2014;20:272. doi: 10.1097/SPV.0000000000000062.
    1. Game X, Khan S, Panicker JN, et al. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity. BJU Int. 2011;107:1786. doi: 10.1111/j.1464-410X.2010.09791.x.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅